← Eichor
Condition: High Risk Cardiovascular Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: High Risk Cardiovascular Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Phase 2 · 1 location(s) · University of Rochester · NCT05597345AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population
Phase N/A · 3 location(s) · China National Center for Cardiovascular Diseases · NCT07277686The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
Phase 4 · 1 location(s) · Brigham and Women's Hospital · NCT05152888Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05776979Discontinuation Study
NA · 1 location(s) · University College Cork · NCT05866757Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-
Phase 2 · 1 location(s) · Carl Ola Landgren, MD, PhD · NCT06100237High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Patients With PAD
NA · 1 location(s) · Centre Hospitalier Universitaire Vaudois · NCT05612945WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
NA · 1 location(s) · Johns Hopkins University · NCT05950659Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patien
NA · 22 location(s) · Samsung Medical Center · NCT07009418A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · 71 location(s) · AstraZeneca · NCT07222917Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding
Phase 4 · 1 location(s) · University of Florida · NCT07025148HFNC vs NIPPV Following Extubation
NA · 1 location(s) · Emory University · NCT05869825Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Thera
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06140966Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension
NA · 4 location(s) · Weill Medical College of Cornell University · NCT07461415The CARDIOPROTECT Trial
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07654426Valveclip® Transcatheter Mitral Valve Repair Study
NA · 1 location(s) · Shanghai NewMed Medical Co., Ltd. · NCT05021614CTSN Embolic Protection Trial
NA · 28 location(s) · Icahn School of Medicine at Mount Sinai · NCT06027788Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Phase 4 · 1 location(s) · Seoul National University Bundang Hospital · NCT07719894Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF
NA · 1 location(s) · University Hospital of Patras · NCT07250529BCMA CAR-T for Dynamic High-risk Multiple Myeloma
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06880393ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07106710Remote Fetal Monitoring in High Risk Pregnancies
Phase N/A · 1 location(s) · Beth Israel Deaconess Medical Center · NCT06822439Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
Phase 3 · 2 location(s) · Jesper Kjaergaard · NCT06453876Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-7
Phase 4 · 1 location(s) · Yonsei University · NCT03770312Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angiop
Phase 3 · 1 location(s) · Cardiocentro Ticino · NCT07582835Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy
Phase N/A · 6 location(s) · University of Athens · NCT06949748The Study to Evaluate the Safety and Efficacy of the Onyx Family
Phase N/A · 1 location(s) · Pusan National University Yangsan Hospital · NCT06577896A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Ident
Phase N/A · 1 location(s) · E.S.stroes · NCT06995183Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism
Phase 3 · 24 location(s) · Supergene, LLC · NCT06362746
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.